The US anti-trust authority Federal Trade Commission (FTC) has cleared Getinge to acquire Atrium Medical for $680m (Enterprise Value).

The US based healthcare company, Atrium Medical, develops, designs, and manufactures cardio-thoracic drainage products, vascular grafts, balloon expandable covered stents, thrombus management catheters and biosurgery products.

Founded in Sweden in 1904, Getinge group is a global medical technology company, which contributes to quality improvement and cost efficiency within healthcare and life sciences.

The acquisition, which was finalized on 4 November 2011, will be consolidated in Getinge’s accounts as of 1 November 2011.